
- Volume 0 0
Bacteria Could Protect Against AIDS Virus
Researchers at Stanford University found that genetically engineered bacteria might be used to help women protect themselves from the AIDS virus. The researchers focused on lactobacilli that naturally live in the vagina. Previous studies have found that women with low levels of lactobacilli may be more likely to contract the AIDS virus.
For the study, the researchers looked at whether the microbes could be made stronger to specifically fight HIV. Therefore, they gave the bacteria an extra boost by adding the gene for CD - 1 of the molecular doorways that HIV uses to get into cells. Peter Lee, MD, lead investigator for the study, said that if HIV latched onto CD4 on a lactobacillus before it reached a human cell, it might remain harmless. Then the bacteria might destroy the virus with naturally produced lactic acid and hydrogen peroxide.
According to results of the study published in Proceedings of the National Academy of Sciences (September 12, 2003), tests on laboratory dishes full of cells showed that the genetically engineered bacteria lowered the rate of HIV infection in cells by at least 50%. Furthermore, early studies with monkeys showed that the engineered bacteria grew well and were safe. If successful, the bacteria could be developed into a vaginal suppository that women could use to protect themselves.
Articles in this issue
almost 22 years ago
Lack of Employment Raises Suicide Riskalmost 22 years ago
Age-Related Dementia Traced to Virusesalmost 22 years ago
Substance Abuse Linked with ADHDalmost 22 years ago
Political Violence Has Lasting Effectalmost 22 years ago
Outlook Is Positive for Getting Olderalmost 22 years ago
They're Still Laughing After All Those Yearsalmost 22 years ago
Mental Decline Goes Unnoticedalmost 22 years ago
Constant Use of the Pill Eases Endometriosisalmost 22 years ago
Diuretics Help Hipsalmost 22 years ago
Eye Disease Grows as Seniors AgeNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.